This month a new drug was introduced on the Canadian market – Wainua (eplontersen) – a medication used for the treatment of transthyretin-mediated amyloidosis.
The original brands of Gluconorm, Cymbalta and Dalacin C are discontinued. We only have generics left – repaglinide, duloxetine, clindamycin, respectively.